Bing

SEARCH HISTORY

Gilead Sciences Inc. (NASDAQ:GILD) [Trend Analysis] moved up around 1% in early trading ... in Rancho Palos Verdes furthermore the William Blair 35th Annual Growth Stock Conference in Chicago. On the other side, Gilead Sciences executives …
streetwisereport.com · 6/10/2015
Mr. Larry Ellberger is a Founding Partner and Principal of Healthcare Ventures Associates, Inc. (HVA, Inc.). Mr. Ellberger served as an Interim Chief Executive Officer of PDI Inc., a sales and marketing service provider for pharmaceutical and biotech ...
Bloomberg · 7/1/2015
You would then have exposure to the below major “types” of cancer immunotherapy Since most of us don’t have the time nor the expertise to stock pick in this “sector”, we look to buy a basket of stocks instead so that if one turns out to go ...
nanalyze.com · 4/22/2015
More from Bing News
It was an impressive turnaround on Tuesday for the stock market as, after Monday's drop, the short-term momentum appeared to be turning negative. Of course, to keep the positive "Mo" going, we need to see further gains Wednesday. A drop back below …
The Money Show · 12/3/2014
The new CEO John Johnson, was the former CEO of Imclone, which was sold to Eli Lilly (LLY). If the launch progress is satisfactory to investors, the stock could continue to retrace some of its losses and lift toward where it traded before Dendreon withdrew ...
Minyanville · 2/25/2012
At the Biotech Showcase 2015 in San Francisco, five biotech analysts examined the burgeoning small-cap life sciences marketplace and found ... He also noted that TG, with a $689M market cap, was a top-performing stock last year in biotech and is the ...
Kaptiall WIre · 1/28/2015
The stock market had a horrible first part of the month ... then the S&P being a mere 2% off its high probably doesn't mean much to you. The pseudonymous trader The Fly — who goes by @the_real_fly on Twitter, and who has been a well-liked member of ...
The Business Insider · ByJoe Weisenthal · 4/26/2014
It’s that time of year again. The world’s biggest gathering of cancer doctors, the American Society of Clinical Oncolgy’s annual confab, kicks off Friday in Chicago, and once again, all eyes are focused on studies regarding so-called immunotherapies ...
Barron's · ByJohanna Bennett · 5/28/2015
Brian Klein, a Vice President with Stifel Nicolaus & Co., says biotechnology investors may want to take a closer look at Clovis Oncology Inc (CLVS),as the company is making some headway on development of a drug to treat lung cancer. “This company is ...
The Wall Street Transcript · 9/30/2014
Launched in 2001, Money Observer Rated Fund Alliance Trust Sustainable Future Global Growth does not boast the most impressive ... Other holdings include Celldex Therapeutics (CLDX), a biotechnology firm pioneering cancer treatments that work with …
Interactive Investor · 5/20/2015